Related references
Note: Only part of the references are listed.The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer
Arti Hurria et al.
CLINICAL BREAST CANCER (2014)
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Patricia A. Ganz et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer
K. L. Pomykala et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Integrating imaging findings in evaluating the post-chemotherapy brain
K. L. Pomykala et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Study of the cognitive effects of chemotherapy: Considerations in selection of a control group
Barbara Collins et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2013)
Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance
Patricia A. Ganz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Bauke Buwalda et al.
LIFE SCIENCES (2013)
Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?
Jeanne S. Mandelblatt et al.
SEMINARS IN ONCOLOGY (2013)
Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study
Carole Scherling et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2012)
Doctor, Will the Treatment You Are Recommending Cause Chemobrain?
Patricia A. Ganz
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
Heather S. L. Jim et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life
Pauline M. Maki et al.
BRAIN RESEARCH (2011)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
Christina M. Schilder et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition
Pauline M. Maki et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Subjective cognitive dysfunction in breast cancer patients: a systematic review
Marleen J. J. Pullens et al.
PSYCHO-ONCOLOGY (2010)
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study
Christina M. Schilder et al.
ACTA ONCOLOGICA (2009)
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2009)
Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review
Barbara B. Sherwin et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Candidate mechanisms for chemotherapy-induced cognitive changes
Tim A. Ahles et al.
NATURE REVIEWS CANCER (2007)
Cognitive impairment associated with adjuvant therapy in breast cancer
Catherine M. Bender et al.
PSYCHO-ONCOLOGY (2006)
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
V Jenkins et al.
BRITISH JOURNAL OF CANCER (2006)
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen
SA Castellon et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2004)
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study
V Jenkins et al.
PSYCHO-ONCOLOGY (2004)
The joint WAIS-III and WMS-III factor structure: Development and cross-validation of a six-factor model of cognitive functioning
DS Tulsky et al.
PSYCHOLOGICAL ASSESSMENT (2003)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research
HS Rugo et al.
SEMINARS IN ONCOLOGY (2003)
Implicit memory varies across the menstrual cycle: estrogen effects in young women
PM Maki et al.
NEUROPSYCHOLOGIA (2002)
Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory
LE Carlson et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2000)